Attached files
| file | filename |
|---|---|
| EX-99.1 - AUSTRALIAN APPENDIX 4C QUARTERLY REPORT FOR THE PERIOD ENDED SEPTEMBER 30, 2012 - REVA Medical, Inc. | d343722dex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report: October 31, 2012
(Date of earliest event reported)
REVA MEDICAL, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 000-54192 | 33-0810505 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) | ||
| 5751 Copley Drive, San Diego, CA | 92111 | |||
| (Address of principal executive offices) | (Zip Code) | |||
(858) 966-3000
(Registrant’s telephone number, including area code)
(Former Name or Former Address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 2.02 | Results of Operations and Financial Condition |
On October 31, 2012 (Australian Eastern Daylight Time), REVA Medical, Inc. filed its Appendix 4C Quarterly Report (“Quarterly Report”) for the three months ended September 30, 2012 with the Australian Securities Exchange (the “ASX”), a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K
The Quarterly Report includes a statement of cash flows prepared in compliance with the requirements of Australian law and the ASX Listing Rules.
Cash on hand at September 30, 2012 as reported in the Quarterly Report was approximately $44.3 million.
| Item 9.01 | Financial Statements and Exhibits. |
| (d) | Exhibits. |
| Exhibit |
Description | |
| 99.1 | Australian Appendix 4C Quarterly Report for the period ended September 30, 2012. | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
| REVA Medical, Inc. | ||||||
| Date: October 31, 2012 | /s/ Katrina L. Thompson | |||||
| Katrina L. Thompson | ||||||
| Chief Financial Officer | ||||||
| (principal financial and accounting officer) | ||||||
Index to Exhibits
| Exhibit Number |
Description of Exhibits | |
| 99.1 | Australian Appendix 4C Quarterly Report for the period ended September 30, 2012. | |